UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 3, 2003
ENDOCARE, INC.
Delaware
(State or other jurisdiction of incorporation)
0-27212 | 33-0618093 | |
(Commission File Number) | (IRS Employer Identification No.) |
201 Technology Drive, Irvine, California 92618
(Address of principal executive offices, including zip code)
(949) 450-5400
(Registrants telephone number, including area code)
ITEM 5. OTHER EVENTS
As previously reported by Endocare, Inc. (the Company) in a press release dated March 12, 2003 and a Form 8-K filed on March 27, 2003, John V. Cracchiolo, has been appointed President of Endocares Interventional Radiology business group. Previously, Mr. Cracchiolo served as the Companys Chief Operating Officer, Chief Financial Officer and Secretary. Mr. Cracchiolos new position will provide him the time to focus on new growth opportunities within the Company. A copy of Mr. Cracchiolos new employment agreement is attached as an exhibit to this Form 8-K.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) | Exhibits. |
99.1 | Employment Agreement, dated March 3, 2003, between Endocare, Inc. and John V. Cracchiolo. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
ENDOCARE, INC | ||
By: /s/ Katherine Greenberg | ||
Date: April 8, 2003 |
|
|
Katherine Greenberg Chief Financial Officer |
2